Original language | English |
---|---|
Pages (from-to) | 25 |
Number of pages | 1 |
Journal | Journal of Pathology |
Volume | 231 |
Publication status | Published - Sept 2013 |
Event | 7th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland - , United Kingdom Duration: 18 Jun 2013 → 21 Jun 2013 |
Combination of HER2-targeted antibodies (Trastuzumab plus Pertuzumab) is effective against HER2 amplified ovarian cancer xenograft models
S. P. Langdon, A. H. Sims, D. J. Harrison
Research output: Contribution to journal › Abstract › peer-review